StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Medivation (MDVN) Could Be Worth Up to $75/Share in a Takeover - Credit Suisse
March 31, 2016 6:24 AM
Credit Suisse analyst Kennen MacKay bumped his price target on Medivation (NASDAQ: MDVN) to $49.00 (from $48.00) following reports the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Hot Comments
Mergers and Acquisitions
Rumors
Next Articles
Prostate Cancer Expert Panel Positive on Medivation's (MDVN) Xtandi, UBS Says; Shares Worth Up to $75 in Takeout
April 4, 2016 9:01 AM
Medivation (MDVN) Worth $51-$75 in Takeover - Jefferies
March 31, 2016 11:40 AM
Medivation (MDVN) Crosses Above 200 DMA Amid Takeover Speculation
March 31, 2016 10:12 AM
Medivation (MDVN) Has Indeed Hired Bakers - CNBC's Tirrell
March 30, 2016 5:32 PM
Medivation (MDVN) Working with JPMorgan on Takeover Approaches - Reuters
March 30, 2016 5:11 PM
Sanofi (SNY) Lines Up Financing for Potential Medivation (MDVN) Takeover Offer - Source
March 30, 2016 4:56 PM
Sanofi (SNY) on watch; Medivation (MDVN) said to defend against potential takeover
March 30, 2016 4:23 PM
Medivation (MDVN) Said to Work with Bankers to Defend Against Takeover (SNY)
March 30, 2016 4:22 PM
